samedan logo
 
 
 
spacer
home > pmps > winter 2002 > label materials for small diameter applications
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Label Materials For Small Diameter Applications

There is no wider area for different types of packaging than the pharmaceutical and medical industries. One look in any pharmacy reveals all types of differently packaged products. Medicines prescribed by a doctor might, for example, be packaged in classic style amber glass bottles with a matt or gloss paper label simply containing data about the medicines. Over the counter (OTC) products are packed in a white polyethylene (PE) container decorated with a multicolour printed high-gloss label. In such cases, suitable labelling materials may be found relatively easily.

However, pharmaceutical labelling applications often involve small diameters. With medical ingredients found in increasingly concentrated dosages, there is a trend towards smaller diameter packaging. And when a squeezable low-density polyethylene (LDPE) nose or eye drop container needs to be labelled, things start to look rather different.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Sven Tolsma, Product Manager at Raflatac
Sven Tolsma has 18 years' work experience in the graphics and paper industries, and has worked for Raflatac since 1994. Raflatac is a leading supplier of paper-based and synthetic self-adhesive labelstock, the material used to make self-adhesive laminate for a wide variety of needs in product and information labelling. Sven was promoted to Product Manager in 1998 and is currently working as part of a product marketing team.

He is responsible for gloss-coated and mid-gloss coated papers, and specialises in pharmaceutical and tyre labelling. He is responsible for identifying supply and demand, applications and trends, and predicting their effect on the labelling industry. Sven utilises this market information to educate end-users' application engineers and label converters' sales forces, as well as the sales force and technical service at Raflatac.

spacer
Sven Tolsma
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In todays tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CROs, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement